Navigation Links
NuMedii, Inc. Announces New Indications Discovery Collaboration With Astellas
Date:1/11/2016

PALO ALTO, Calif., Jan. 11, 2016 /PRNewswire/ -- NuMedii, Inc. today announced the formation of a discovery collaboration with Astellas Pharma Inc. ("Astellas") to identify new indications for a number of undisclosed Astellas compounds using NuMedii's predictive Big Data intelligence technology.

"NuMedii's predictive Big Data intelligence technology enables the discovery of new uses for both marketed drugs and shelved development assets across a number of therapeutic areas," stated Asim Siddiqui, Ph.D., chief technology officer, NuMedii, Inc. "We are excited to partner with Astellas to explore new indications for a number of their assets which we hope will be of benefit to patients in need and the physicians who treat them."

This is NuMedii's second collaboration with a large pharmaceutical company in recent months. In September 2015, the Company announced a partnership with Allergan for discovery of new treatments for psoriasis.

The Company's proprietary and dynamic Big Data intelligence technology consists of hundreds of millions of human, biological, pharmacological and clinical data points that NuMedii has normalized and annotated. NuMedii integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases. In 2013, NuMedii entered into a strategic technology partnership with the Intellectual Property and Life Science business of Thomson Reuters, creating an unprecedented repository of methodologies and content to systematically identify new applications for existing drug compounds. NuMedii is initially using its Big Data technology to discover and de-risk new indications for medicines.

Financial terms of the agreement were not disclosed.

About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at http://www.astellas.com.

About NuMedii, Inc.

NuMedii, Inc., discovers effective new drugs by translating its predictive data intelligence technology into therapies with a higher probability of therapeutic success. The Company's exclusive Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. NuMedii translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. Headquartered in Palo Alto, California, NuMedii's investors include Claremont Creek Ventures and Lightspeed Venture Partners. For more information, please visit www.numedii.com.

 


'/>"/>
SOURCE NuMedii, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. NuMedii, Inc. Announces Research Collaboration with Allergan To Explore New Treatments For Psoriasis
2. Medicure Announces Preliminary Revenue For Fiscal 2015
3. Worlds Largest Materials Science Catalog Announces Launch Of New Website
4. Agena Bioscience Announces the Expansion of its Headquarters in San Diego, California, to Better Serve its Growing Customer Base
5. Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue
6. Sorrento Announces Positive Data from Phase 3 studies of Biosimilar Antibodies, STI-001 and STI-002
7. Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results
8. Exact Sciences Announces Contract with Anthem BlueCross of California
9. IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year
10. Accuray Announces Preliminary Second Quarter Financial Results
11. SciClone Announces Preliminary 2015 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted ... suffering in embittered divorce battles make better decisions and become truly child focused. This ... a bully, be resilient, and STOP the cycle! Don’t be a divorce bully!” (published ...
(Date:10/11/2019)... , ... October 11, 2019 , ... ... starting October 13, 2019, to recognize the dedication, compassion and quality patient outcomes ... collaborative process, providing a unique and vital link between patients, providers and payers ...
(Date:10/10/2019)... ... October 10, 2019 , ... Ovation Fertility is once again ... reproductive medicine, with six abstracts accepted for poster presentations at the ASRM 2019 ... 12-16, 2019, in Philadelphia. , “Ovation will have a prominent presence in the ...
Breaking Medicine Technology:
(Date:10/10/2019)... ... ... Caring.com, a leading senior care referral service with Family Advisors nationwide, released ... Live. All 50 states and 302 cities in the U.S. were ranked based on ... According to the U.S. Census Bureau , almost 20 million Americans will be ...
(Date:10/8/2019)... , ... October 08, 2019 , ... SoCal Adolescent Wellness ... happy to announce the expansion of our services to better serve the families in ... over this last year to see the extraordinary impact this pre-intervention program has on ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... West Hartford, CT, help patients with missing teeth restore their smiles with long-lasting ... of oral surgeons relies on advanced i-CAT® 3D Cone Beam CT imaging, X-Guide™ ...
(Date:10/8/2019)... MARINA DEL REY, Calif. (PRWEB) , ... October ... ... Quality Confab for laboratory managers, administrators and pathologists, 4medica® President ... Perfect Payment™ is the first-to-market solution reinventing labs orders management-by starting with ...
(Date:10/8/2019)... ... October 08, 2019 , ... EBSCO Information Services ... skills and procedures content from Dynamic Health™ into the MCN platform. ... professionals master critical skills. MCN provides custom policy content, document management software and ...
Breaking Medicine News(10 mins):